Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ: LGND · Real-Time Price · USD

303.53

-4.29 (-1.39%)

At close: Oct 23, 2026, 4:00 PM EDT

303.53

0.00 (0.00%)

After-hours: Oct 23, 2026, 5:09 PM EDT

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	6,051	3,721	2,025	1,245	1,128	2,581
Market Cap Growth	65.42%	83.80%	62.59%	10.35%	-56.28%	61.40%
Enterprise Value	5,825	3,508	1,812	1,061	1,121	2,589
Last Close Price	303.53	189.07	107.15	71.42	66.80	99.67

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	33.02	29.90	-	23.88	-	45.18
Forward PE	43.81	35.20	53.58	35.07	298.37	298.37
PS Ratio	20.83	13.88	12.11	9.48	5.75	10.69
PB Ratio	6.25	3.66	2.44	1.78	1.89	3.14
P/TBV Ratio	9.21	5.39	4.42	4.18	8.11	7.85
P/FCF Ratio	46.04	76.09	21.26	27.04	8.99	36.86
P/OCF Ratio	45.94	75.39	20.86	25.12	8.19	32.76
PEG Ratio	1.80	2.42	3.57	2.34	23.42	18.19

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	20.05	13.08	10.84	8.08	5.71	10.72
EV/EBITDA Ratio	43.79	43.32	31.11	22.90	27.11	22.09
EV/EBIT Ratio	58.19	74.32	78.73	108.04	369.11	39.07
EV/FCF Ratio	44.32	71.72	19.03	23.04	8.93	36.96

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	1.17	0.44	0.01	0.01	0.15	0.40
Debt / EBITDA Ratio	8.46	5.52	0.12	0.13	2.09	2.74
Debt / FCF Ratio	8.61	9.23	0.08	0.13	0.70	4.63
Net Debt / Equity Ratio	-0.23	-0.28	-0.30	-0.23	-0.21	-0.02
Net Debt / EBITDA Ratio	-1.70	-3.48	-4.27	-3.54	-3.00	-0.14
Net Debt / FCF Ratio	-1.72	-5.77	-2.61	-3.56	-0.99	-0.24
Asset Turnover	0.19	0.21	0.19	0.17	0.19	0.18
Inventory Turnover	4.24	8.24	1.71	1.88	4.38	3.50
Quick Ratio	30.83	21.83	8.32	12.49	2.50	10.39
Current Ratio	31.18	22.23	8.93	14.15	2.67	11.15
Return on Equity (ROE)	21.96%	13.47%	-0.53%	8.29%	-0.74%	9.98%
Return on Assets (ROA)	3.99%	2.36%	1.66%	0.79%	0.18%	3.11%
Return on Invested Capital (ROIC)	11.76%	5.61%	-6.59%	1.64%	-0.07%	8.50%
Return on Capital Employed (ROCE)	4.70%	3.10%	2.50%	1.30%	0.50%	5.30%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	3.03%	3.34%	-0.20%	4.19%	-2.96%	2.21%
FCF Yield	2.17%	1.31%	4.70%	3.70%	11.12%	2.71%
Buyback Yield / Dilution	-12.96%	-10.96%	-3.00%	-5.27%	2.19%	-2.50%

SEC Filings: 10-K · 10-Q